Researchers from the University of Plymouth have discovered the tole PrPC plays in the development of neurofibromatosis 2 tumors. According to the study, the prion protein is overproduced in schwannomas, compared with healthy Schwann cells. This overproduction is a result of Merlin deficiency and contributed to tumor growth in NF2 patients.
Researchers believe their findings could lead to new targets for brain cancer therapies.
According to researchers, targeting multiple angiogenesis pathways simultaneously could help overcome the resistance to anti-angiogenic treatment developed by glioblastoma brain cancer.
Researchers uncover a possible reason as to why astrocytomas don't respond to standard forms of cancer treatment.
A new study reports adults who survived posterior fossa brain tumors as children have lower working memory performance than healthy adults.
A new study reports changes in immune function can occur up to five years before the diagnosis of brain cancer, which typically only produces symptoms three months before it is detected.